Film Exhibition Industry On The Cusp Of Normality With Vaccines Arriving, Says Nirmal Bang
BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
Nirmal Bang Report
With Indian government about to embark on a large scale vaccination exercise, we believe that by Q2 FY22 the film exhibition industry should achieve a semblance of normality.
While many other sectors have been able to get their revenues back to almost pre-Covid-19 levels, the Indian Film exhibition sector has borne the brunt of the pandemic and will likely be among the last to get back to normality.
Consequent to the vaccine news, we have tweaked our estimates, resulting in FY23 Ebitda being largely unchanged. But, FY21 is going to be far worse than anticipated.
Click on the attachment to read the full report:
This report is authored by an external party. BloombergQuint does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BloombergQuint.
Users have no license to copy, modify, or distribute the content without permission of the Original Owner.